| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Locked | Locked | Locked | Locked | Locked | Locked | Locked | $55,200 | -0 |
| Locked | Locked | Locked | Locked | Locked | Locked | Locked | $92,500 | -0 |
| Locked | Locked | Locked | Locked | Locked | Locked | Locked | $61,350 | -0 |
| Locked | Locked | Locked | Locked | Locked | Locked | Locked | $75,300 | -0 |
| Locked | Locked | Locked | Locked | Locked | Locked | Locked | $1M | -0 |
| Jul 15, 2021 | Jul 19, 2021 | Abercrombie George B Dir | Sell | Biocryst Pharmaceuticals Inc | BCRX | $15.69 | $78,450 | -62.50% |
| May 24, 2021 | May 26, 2021 | Abercrombie George B Dir | Sell | Biocryst Pharmaceuticals Inc | BCRX | $13.9 | $92,671 | -68.97% |
| May 10, 2021 | May 12, 2021 | Abercrombie George B Dir | Sell | Biocryst Pharmaceuticals Inc | BCRX | $12.7 | $88,900 | -70.00% |
| Aug 21, 2018 | Aug 22, 2018 | Abercrombie George B SVP Chief Comm. Officer | Sell | Innoviva, Inc. | INVA | $14.11 | $112,840 | -2.73% |
| May 21, 2018 | May 22, 2018 | Abercrombie George B SVP Chief Comm. Officer | Sell | Innoviva, Inc. | INVA | $14.4 | $115,202 | -2.60% |
| Feb 21, 2018 | Feb 22, 2018 | Abercrombie George B SVP Chief Comm. Officer | Sell | Innoviva, Inc. | INVA | $16.51 | $132,100 | -3.29% |
| Nov 21, 2017 | Nov 22, 2017 | Abercrombie George B SVP Chief Comm. Officer | Sell | Innoviva, Inc. | INVA | $13.26 | $69,145 | -1.98% |
| Nov 12, 2013 | Nov 13, 2013 | Abercrombie George B Dir | Buy | Biocryst Pharmaceuticals Inc | BCRX | $6.19 | $18,570 | +33.33% |